Mumbai: Chennai-based medical technology company Trivitron Healthcare said on Friday it has acquired Finnish diagnostics technology Ani Labsystems for €15.8 million (about Rs.110 crore).
Ani Labsystems is a group of companies comprising Ani Biotech, Ani Labsystems, Biopoint and K3. Trivitron has acquired all these companies and will merge them into Labsystems Diagnostics OY, a Trivitron group firm.
With this acquisition, Trivitron will have the capability to enter into point-of-care, immuno and molecular diagnostics, the three of the fastest growing areas in the in-vitro diagnostics field, the company said in a statement.
“The factory based in India will enable Trivitron’s access to new infectious disease testing products for emerging markets and offer their customers new value oriented product lines in South Asia, South East Asia, Middle East and Africa,” Trivitron founder and managing director G.S.K. Velu said in the statement.